Empagliflozin ameliorates vascular calcification in diabetic mice through inhibiting Bhlhe40-dependent NLRP3 inflammasome activation-Reference-Cited by-同舟云学术

Empagliflozin ameliorates vascular calcification in diabetic mice through inhibiting Bhlhe40-dependent NLRP3 inflammasome activation

Published:2024-01-03 Issue:4 Volume:45 Page:751-764
ISSN:1671-4083
Container-title:Acta Pharmacologica Sinica
language:en
Short-container-title:Acta Pharmacol Sin

Author:

Li Xiao-xue,Chen Zheng-dong,Sun Xue-jiao,Yang Yi-qing,Jin Hong,Liu Nai-feng

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41401-023-01217-0.pdf

Reference66 articles.

1. Lehker A, Mukherjee D. Coronary calcium risk score and cardiovascular risk. Curr Vasc Pharmacol. 2021;19:280–4.

2. Shanahan CM, Crouthamel MH, Kapustin A, Giachelli CM. Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ Res. 2011;109:697–711.

3. Nicoll R, Henein MY. The predictive value of arterial and valvular calcification for mortality and cardiovascular events. Int J Cardiol Heart Vessel. 2014;3:1–5.

4. Leopold JA. Vascular calcification: mechanisms of vascular smooth muscle cell calcification. Trends Cardiovasc Med. 2015;25:267–74.

5. Everhart JE, Pettitt DJ, Knowler WC, Rose FA, Bennett PH. Medial arterial calcification and its association with mortality and complications of diabetes. Diabetologia. 1988;31:16–23.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NLRP3 inflammasomes as a target for hesperidin and diosmin flavonoids in varicose vein disease and its complications;Almanac of Clinical Medicine;2024-08-12

2. Longitudinal assessment of coronary plaque regression related to sodium–glucose cotransporter-2 inhibitor using coronary computed tomography angiography;Cardiovascular Diabetology;2024-07-22

3. Complex actions of sodium glucose transporter-2 inhibitors on lipids, calcific atherosclerosis, and bone density;Current Opinion in Lipidology;2024-07-18

4. Sodium-glucose cotransporter 2 inhibitors attenuate vascular calcification by suppressing endoplasmic reticulum protein thioredoxin domain containing 5 dependent osteogenic reprogramming;Redox Biology;2024-07

5. Effects of Empagliflozin on Vascular and Skeletal Mineralization in Hyperlipidemic Mice;Vascular Pharmacology;2024-06